|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MICROCIDE PHARMACEUTICALS INC, 10-Q/A, EX-10.30, 2000-06-19 |
Next: ORION ACQUISITION CORP II, 4, 2000-06-19 |
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0001010915
<NAME> MICROCIDE PHARMACEUTICALS, INC.
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> MAR-31-2000
<EXCHANGE-RATE> 1
<CASH> 4,704
<SECURITIES> 16,230
<RECEIVABLES> 849
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 22,093
<PP&E> 20,027
<DEPRECIATION> (12,823)
<TOTAL-ASSETS> 30,220
<CURRENT-LIABILITIES> 3,408
<BONDS> 0
0
0
<COMMON> 67,888
<OTHER-SE> (42,837)
<TOTAL-LIABILITY-AND-EQUITY> 30,220
<SALES> 0
<TOTAL-REVENUES> 1,133
<CGS> 0
<TOTAL-COSTS> 4,899
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 77
<INCOME-PRETAX> (3,520)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,520)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,520)
<EPS-BASIC> (0.31)
<EPS-DILUTED> (0.31)
</TABLE>
|
|